Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bioequivalence Study of Pentoxifylline 400 Mg in Sustained Release Tablets in Sustained Release Tablets in Healthy Subjects Under Fasting and Fed Conditions

NCT06823362 is registered in ClinicalTrials.gov with Centro de Atencion e Investigacion Medica as lead sponsor.

NCT NCT06823362
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06823362 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bioequivalence Study of Pentoxifylline 400 Mg in Sustained Release Tablets in Sustained Release Tablets in Healthy Subjects Under Fasting and Fed Conditions
Lead sponsor
Centro de Atencion e Investigacion Medica
Phase
Phase 4
Overall status
Not yet recruiting
Start date
April 10, 2025
Completion date
September 30, 2025
Enrollment
40 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

healthy, healthy donors